WebMD12d
Thymidine Kinase 2 Deficiency (TK2d)
What Is Thymidine Kinase 2 Deficiency (TK2d)? Thymidine kinase 2 deficiency (TK2d) mainly causes muscle weakness – it’s a very rare mitochondrial disease. Mitochondria are tiny organ-like ...
New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference
UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...
The Pharma Letter13d
UCB presents new data on thymidine kinase 2 deficiency treatment
Belgium’s largest drugmaker UCB (Euronext: UCB) today announced positive data from studies involving its investigational ...
PharmiWeb13d
New data on investigational therapy for thymidine…
UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...
Le Moniteur des pharmacies7d
Lonsurf : sa prise en charge est étendue
Le Journal officiel du 25 mars 2025 annonce l’extension de la prise en charge de l'anticancéreux Lonsurf (trifluridine et ...
Morningstar13d
New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference
1,2,3 Thymidine kinase 2 deficiency is an ultra-rare, life-threatening, genetic mitochondrial disease characterized by progressive and severe muscle weakness (myopathy), which can impact the ...